<DOC>
	<DOCNO>NCT01217892</DOCNO>
	<brief_summary>This study carry see dapagliflozin - administer daily dose 2.5 mg give twice day 5 mg twice day 10mg daily - addition metformin , beneficial diabetes treatment , , compare treatment metformin alone .</brief_summary>
	<brief_title>Evaluation Dapagliflozin Taken Twice-daily</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Provision inform consent prior study specific procedure Diagnosis T2DM Current antihyperglycaemic treatment metformin immediate release formulation monotherapy &gt; /= 1500 mg/day stable dose least 10 week prior enrolment . Other treatment OADs within 10 week prior enrolment permit . HbA1c ≥ 6.7 % ≤10.5 % , base central laboratory value Screening Visit , Enrolment Visit 1 . Diagnosis Type 1 diabetes mellitus , know diagnosis Maturity Onset Diabetes Young ( MODY ) secondary cause diabetes mellitus History diabetic ketoacidosis Symptoms poorly control diabetes include , limited , marked polyuria , polydipsia , and/or great 10 % weight loss 3 month prior enrolment FPG &gt; 270 mg/dL ( &gt; 15.0 mmol/L ) BMI &gt; 45 kg/m2</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>77 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Type 2 diabetes</keyword>
	<keyword>metformin treat</keyword>
	<keyword>inadequate control</keyword>
	<keyword>metformin treatment alone</keyword>
</DOC>